** Dice Therapeutics Inc DICE.O launches equity offering
after its shares jump
** DICE on Tues hit record high of $45.99 before finishing
up 62.3% at $40.00 on Tues after experimental psoriasis drug
showed clinical proof-of-concept in early-stage study
urn:newsml:reuters.com:*:nL4N31C2OB
** Co expects to advance drug to mid-stage study in Q1 2023
** After the bell, co commences $250 mln stock offering
urn:newsml:reuters.com:*:nGNXfsvCS
** BofA, SVB Securities, Evercore and Guggenheim jt
bookrunners; offering slated to price Weds after market close
** DICE has ~$1.5 bln market cap, including gain on Tues
** Shares dip ~1% in extended trading. Co went public in
Sept 2021 after 12 mln share IPO priced at $17
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))